Stock Events

Stock Events

KNC Laboratories.

€6.48

0

-€0.02-0.31% 07:55 Today

Statistics

Day High

6.48

Day Low

6.47

52W High

6.52

52W Low

5.46

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

1.43%

Dividend

0.09

Upcoming

Dividend Payment

Dividend Payment

Dividends

1.43%Dividend Yield

Jun 26

€0.09

Dec 25

€0.09

Jun 25

€0.10

Dec 24

€0.10

Jun 24

€0.09

10Y Growth

-54.5%

5Y Growth

-1.48%

3Y Growth

-6.42%

1Y Growth

-8.65%

Earnings

7AugExpected

Q1 2026

Next

0.46

0.79

1.13

1.46

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 7LW.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Astellas Pharma

Astellas Pharma Inc. competes in the pharmaceutical sector, developing products that can overlap with KNC Laboratories' healthcare offerings.

Sumitomo Pharma.

Sumitomo Pharma Co., Ltd. operates in the same industry, focusing on pharmaceuticals and chemicals, directly competing with KNC's product lines.

Shionogi & Co., Ltd. is a major player in the pharmaceutical industry in Japan, offering similar products and competing in the same markets as KNC Laboratories.

Chugai Pharmaceutical

Chugai Pharmaceutical Co., Ltd. specializes in biopharmaceuticals, a field relevant to KNC Laboratories' interests in medical and health-related products.

Eisai Co., Ltd. is involved in the development of pharmaceutical solutions and life sciences, areas where KNC Laboratories also operates.

Daiichi Sankyo.

Daiichi Sankyo Company, Limited focuses on pharmaceuticals, including research and development in medicine, competing with KNC Laboratories in healthcare solutions.

Otsuka Holdings Co., Ltd. offers a diverse range of pharmaceutical products, directly competing with KNC Laboratories in multiple healthcare segments.

Kyowa Kirin Co., Ltd. focuses on pharmaceuticals and biotechnologies, directly competing with KNC Laboratories in the development of medical treatments and solutions.

Nippon Shinyaku Co., Ltd. competes in the pharmaceutical industry, offering products that can directly compete with KNC Laboratories' offerings.

Fujifilm Holdings Corporation, though primarily known for imaging, also has significant healthcare divisions that compete with KNC Laboratories in medical products and innovations.

About

KNC Laboratories Co., Ltd. engages in the research, development, and production solutions of organic chemicals in Japan. It offers products for use in the pharmaceutical, electronic-chemical, agrochemical, energy, and environment fields. The company offers support services for drugs and functional chemicals. KNC Laboratories Co., Ltd. was founded in 1985 and is headquartered in Kobe, Japan.

Show more...

CEO

ISIN

JP3290400005

WKN

000A2JK64

Listings

0 Comments

Share your thoughts

FAQ

What is KNC Laboratories. stock price today?▼

The current price of 7LW.F is €6.48 EUR — it has decreased by -0.31% in the past 24 hours. Watch KNC Laboratories. stock price performance more closely on the chart.

What is KNC Laboratories. stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange KNC Laboratories. stocks are traded under the ticker 7LW.F.

When is the next KNC Laboratories. earnings date?▼

KNC Laboratories. is going to release the next earnings report on August 07, 2026.

What were KNC Laboratories. earnings last quarter?▼

7LW.F earnings for the last quarter are 0.46 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.

Does KNC Laboratories. pay dividends?▼

Yes, 7LW.F dividends are paid semi-annual. The last dividend per share was 0.09 EUR. As of today, Dividend Yield (FWD)% is 1.43%.

In which sector is KNC Laboratories. located?▼

KNC Laboratories. operates in the Other sector.

When did KNC Laboratories. complete a stock split?▼

KNC Laboratories. has not had any recent stock splits.